Ad is loading...
AMBFX
Price
$36.40
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
RLBGX
Price
$36.45
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

AMBFX vs RLBGX

Header iconAMBFX vs RLBGX Comparison
Open Charts AMBFX vs RLBGXBanner chart's image
American Funds American Balanced F2
Price$36.40
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R6
Price$36.45
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
AMBFX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMBFX vs. RLBGX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBFX is a StrongBuy and RLBGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
AMBFX (237B) and RLBGX (237B) have equal amount of cash in the bank . RLBGX (2.55) and AMBFX (2.46) have matching dividends . AMBFX was incepted earlier than RLBGX: AMBFX (16 years) vs RLBGX (16 years). AMBFX (171.00) and RLBGX (171.00) have comparable annual turnover. AMBFX (250) and RLBGX (250) have matching initial minimum investment requirements. RLBGX (21.19) and AMBFX (21.06) have marching annual gain over last year. RLBGX (38.23) and AMBFX (37.62) have equivalent 5 years return.
AMBFXRLBGXAMBFX / RLBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years16 years-
Gain YTD15.17015.27199%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets237B237B100%
Annual Yield % from dividends2.462.5596%
Returns for 1 year21.0621.1999%
Returns for 3 years12.6512.9298%
Returns for 5 years37.6238.2398%
Returns for 10 years52.8353.7398%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORLA4.600.25
+5.75%
Orla Mining Ltd
SENS0.320.01
+1.70%
Senseonics Holdings
RCL237.571.70
+0.72%
Royal Caribbean Group
SYM36.27-0.04
-0.11%
Symbotic
CTXR0.17N/A
-2.83%
Citius Pharmaceuticals